Topical treatment with 13-cis-retinoic acid improves Darier's disease and induces the expression of a unique keratin pattern

Dermatologica. 1991;182(3):178-83. doi: 10.1159/000247778.

Abstract

A patient with Darier's disease was treated topically with either 13-cis-retinoic acid 0.1%, all-trans-retinoic acid 0.05% or their cream base only. Both 13-cis-retinoic acid and all-trans-retinoic acid were effective. However, all-trans-retinoic acid had to be discontinued because of irritation. By contrast, 13-cis-retinoic acid was well tolerated and resulted in a complete remission. Both retinoids caused a marked change in the expression of cytokeratins. The most remarkable observation was the expression of cytokeratins 4, 13 and 19 at retinoid-treated areas. These cytokeratins are absent in adult normal or diseased epidermis and hence provide a cell-biological tool to substantiate a retinoid effect.

Publication types

  • Case Reports
  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Darier Disease / drug therapy*
  • Darier Disease / metabolism
  • Darier Disease / pathology
  • Double-Blind Method
  • Emollients
  • Humans
  • Immunohistochemistry
  • Keratins / analysis
  • Male
  • Middle Aged
  • Tretinoin / administration & dosage
  • Tretinoin / adverse effects
  • Tretinoin / therapeutic use*

Substances

  • Emollients
  • Tretinoin
  • Keratins